AutonoMIA is an immersive exploration that can be leveraged to re-enchant the driving experience of the future by through cutting-edge technologies.
This new initiative comprises steps aimed at promoting the health & safety of its stakeholders while ensuring optimum production levels at its plant.
Mahindra’s Group Chief Economist analyzes the Rs. 20 lakh crore COVID relief financial package recently announced by the Government of India.
Unique new financing schemes are yet another step by Mahindra Automotive to support its customers during these challenging times.
Tech Mahindra conducts molecular docking studies of 19 Food and Drug Administration (FDA) approved ligands and anti-viral drugs.